UChicago Medicine, alongside speakers Michael R. Bishop & Olatoyosi Odenike, explore 'New therapeutic Approaches for Hematologic Malignancies in Adults' in this webinar update, now available to view for free on demand.
In recent years, our increasing understanding of the molecular pathophysiology of hematologic malignancies has paved the way for new targeted and cellular therapeutic approaches. However, the cure rate for acute myeloid leukemia and related high-risk myeloid malignancies, particularly in older adults, remains low.
Newer approaches are improving the remission rates in myeloid malignancies, improving overall survival, and improved supportive care has allowed older patients the opportunity of curative strategies such as allogeneic stem cell transplantation. Similarly, novel therapies have resulted in improved and prolonged remissions rates in other hematologic malignancies, such as lymphoma and myeloma; however, relapse remains a major issue. Chimeric antigen receptor (CAR) T cells have provided a major option for lymphoma and myeloma patients with relapsed disease.
This webinar focuses on recent advances in the treatment of older adults with high-risk myeloid malignancies and the increasing use of cellular therapeutics in the management of hematologic malignancies.